A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production

Abdul Gafoor Puthiyaveetil, Bettina Heid, Christopher M. Reilly, Harm HogenEsch, David L. Caudell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Myelodysplastic syndrome is a clonal process characterized by ineffective hematopoiesis and progression to acute leukemia. Although many myelodysplastic syndrome and leukemic patients have compromised immunity, the role of underlying mutations in regulating immune function is poorly understood. Recent studies show that NUP98-HOXD13 (NHD13) fusion gene results in myelodysplastic syndrome and impairs lymphocyte differentiation in transgenic mice. In our studies, we sought to elucidate the mechanism by which NHD13 affects B-lymphocyte development and function. Based on our preliminary findings that transgenic mice had increased levels of IgM and reduced IgG1 and IgE, we hypothesized that the fusion gene might impair class switch recombination (CSR). Mice were immunologically challenged with dinitrophenol. NHD13 mice showed a marked reduction in B-lymphocyte differentiation in their bone marrow and spleen following dinitrophenol stimulation and had reduced production of dinitrophenol-specific antibodies. Spleen follicles from these mice were small and hypocellular, indicating failure of clonal expansion. When isolated NHD13 B lymphocytes were stimulated in vitro using Escherichia coli lipopolysaccharide or lipopolysaccharide + interleukin-4, they failed to undergo sufficient CSR and proliferation. Taken together, our findings show that expression of NUP98-HOXD13 impairs CSR and reduces the antibody-mediated immune response, in addition to its role in leukemia. Further delineation of the NUP98-HOXD13 transgene may reveal novel pathways involved in CSR.

Original languageEnglish (US)
Pages (from-to)622-633
Number of pages12
JournalExperimental Hematology
Volume40
Issue number8
DOIs
StatePublished - Aug 2012
Externally publishedYes

Fingerprint

Gene Fusion
Genetic Recombination
Antibody Formation
Dinitrophenols
Myelodysplastic Syndromes
B-Lymphocytes
Transgenic Mice
Lipopolysaccharides
Leukemia
Spleen
Antibodies
Hematopoiesis
Transgenes
Interleukin-4
Immunoglobulin E
Immunoglobulin M
nuclear pore complex protein 98
Immunity
Immunoglobulin G
Bone Marrow

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Cite this

A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production. / Puthiyaveetil, Abdul Gafoor; Heid, Bettina; Reilly, Christopher M.; HogenEsch, Harm; Caudell, David L.

In: Experimental Hematology, Vol. 40, No. 8, 08.2012, p. 622-633.

Research output: Contribution to journalArticle

Puthiyaveetil, Abdul Gafoor ; Heid, Bettina ; Reilly, Christopher M. ; HogenEsch, Harm ; Caudell, David L. / A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production. In: Experimental Hematology. 2012 ; Vol. 40, No. 8. pp. 622-633.
@article{68692345cb774d62904197c11a03b231,
title = "A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production",
abstract = "Myelodysplastic syndrome is a clonal process characterized by ineffective hematopoiesis and progression to acute leukemia. Although many myelodysplastic syndrome and leukemic patients have compromised immunity, the role of underlying mutations in regulating immune function is poorly understood. Recent studies show that NUP98-HOXD13 (NHD13) fusion gene results in myelodysplastic syndrome and impairs lymphocyte differentiation in transgenic mice. In our studies, we sought to elucidate the mechanism by which NHD13 affects B-lymphocyte development and function. Based on our preliminary findings that transgenic mice had increased levels of IgM and reduced IgG1 and IgE, we hypothesized that the fusion gene might impair class switch recombination (CSR). Mice were immunologically challenged with dinitrophenol. NHD13 mice showed a marked reduction in B-lymphocyte differentiation in their bone marrow and spleen following dinitrophenol stimulation and had reduced production of dinitrophenol-specific antibodies. Spleen follicles from these mice were small and hypocellular, indicating failure of clonal expansion. When isolated NHD13 B lymphocytes were stimulated in vitro using Escherichia coli lipopolysaccharide or lipopolysaccharide + interleukin-4, they failed to undergo sufficient CSR and proliferation. Taken together, our findings show that expression of NUP98-HOXD13 impairs CSR and reduces the antibody-mediated immune response, in addition to its role in leukemia. Further delineation of the NUP98-HOXD13 transgene may reveal novel pathways involved in CSR.",
author = "Puthiyaveetil, {Abdul Gafoor} and Bettina Heid and Reilly, {Christopher M.} and Harm HogenEsch and Caudell, {David L.}",
year = "2012",
month = "8",
doi = "10.1016/j.exphem.2012.05.002",
language = "English (US)",
volume = "40",
pages = "622--633",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production

AU - Puthiyaveetil, Abdul Gafoor

AU - Heid, Bettina

AU - Reilly, Christopher M.

AU - HogenEsch, Harm

AU - Caudell, David L.

PY - 2012/8

Y1 - 2012/8

N2 - Myelodysplastic syndrome is a clonal process characterized by ineffective hematopoiesis and progression to acute leukemia. Although many myelodysplastic syndrome and leukemic patients have compromised immunity, the role of underlying mutations in regulating immune function is poorly understood. Recent studies show that NUP98-HOXD13 (NHD13) fusion gene results in myelodysplastic syndrome and impairs lymphocyte differentiation in transgenic mice. In our studies, we sought to elucidate the mechanism by which NHD13 affects B-lymphocyte development and function. Based on our preliminary findings that transgenic mice had increased levels of IgM and reduced IgG1 and IgE, we hypothesized that the fusion gene might impair class switch recombination (CSR). Mice were immunologically challenged with dinitrophenol. NHD13 mice showed a marked reduction in B-lymphocyte differentiation in their bone marrow and spleen following dinitrophenol stimulation and had reduced production of dinitrophenol-specific antibodies. Spleen follicles from these mice were small and hypocellular, indicating failure of clonal expansion. When isolated NHD13 B lymphocytes were stimulated in vitro using Escherichia coli lipopolysaccharide or lipopolysaccharide + interleukin-4, they failed to undergo sufficient CSR and proliferation. Taken together, our findings show that expression of NUP98-HOXD13 impairs CSR and reduces the antibody-mediated immune response, in addition to its role in leukemia. Further delineation of the NUP98-HOXD13 transgene may reveal novel pathways involved in CSR.

AB - Myelodysplastic syndrome is a clonal process characterized by ineffective hematopoiesis and progression to acute leukemia. Although many myelodysplastic syndrome and leukemic patients have compromised immunity, the role of underlying mutations in regulating immune function is poorly understood. Recent studies show that NUP98-HOXD13 (NHD13) fusion gene results in myelodysplastic syndrome and impairs lymphocyte differentiation in transgenic mice. In our studies, we sought to elucidate the mechanism by which NHD13 affects B-lymphocyte development and function. Based on our preliminary findings that transgenic mice had increased levels of IgM and reduced IgG1 and IgE, we hypothesized that the fusion gene might impair class switch recombination (CSR). Mice were immunologically challenged with dinitrophenol. NHD13 mice showed a marked reduction in B-lymphocyte differentiation in their bone marrow and spleen following dinitrophenol stimulation and had reduced production of dinitrophenol-specific antibodies. Spleen follicles from these mice were small and hypocellular, indicating failure of clonal expansion. When isolated NHD13 B lymphocytes were stimulated in vitro using Escherichia coli lipopolysaccharide or lipopolysaccharide + interleukin-4, they failed to undergo sufficient CSR and proliferation. Taken together, our findings show that expression of NUP98-HOXD13 impairs CSR and reduces the antibody-mediated immune response, in addition to its role in leukemia. Further delineation of the NUP98-HOXD13 transgene may reveal novel pathways involved in CSR.

UR - http://www.scopus.com/inward/record.url?scp=84864012210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864012210&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2012.05.002

DO - 10.1016/j.exphem.2012.05.002

M3 - Article

C2 - 22613470

AN - SCOPUS:84864012210

VL - 40

SP - 622

EP - 633

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 8

ER -